Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/8342
Title: Reduced Ovarian Reserve in Patients with Takayasu Arteritis
Authors: MONT'ALVERNE, Andrea Rocha S.PEREIRA, Rosa Maria R.YAMAKAMI, Lucas Yugo S.VIANA, Vilma Santos T.BARACAT, Edmund ChadaBONFA, EloisaSILVA, Clovis Artur
Citation: JOURNAL OF RHEUMATOLOGY, v.41, n.10, p.2055-2059, 2014
Abstract: Objective. To assess ovarian reserve markers in patients with Takayasu arteritis (TA). Methods. Twenty patients with TA and 24 healthy controls were evaluated for ovarian reserve by follicle-stimulating hormone, luteinizing hormone, and estradiol, and antral follicle count (AFC). Anti-Mullerian hormone (AMH) was measured by ELISA using 2 different kits. Demographical data, menstrual abnormalities, disease variables, and treatment were also analyzed. Results. The median current age was similar in patients with TA and controls (31.2 +/- 6.1 vs 30.4 +/- 6.9 yrs, p = 0.69). The frequencies of decreased levels of AMH in patients with TA were identical using both kits and higher when compared to controls (50% vs 17%, p = 0.02; 50% vs 19%, p = 0.048). A positive correlation was observed between the 2 kits in patients with TA (r = + 0.93, p < 0.0001) and in healthy controls (r = + 0.93, p < 0.0001). The apparent lower AFC (11 vs 16, p = 0.13) and the higher frequency of low AFC (41% vs 22%, p = 0.29) in TA compared to controls did not reach statistical significance. Other hormones were similar in both groups (p > 0.05). Further evaluation of patients with TA with low AMH levels (< 1.0 ng/ml) versus normal AMH levels (> 1.0 ng/ml) revealed that the frequency of current disease activity (p = 1.0) and the median of erythrocyte sedimentation rate (p = 0.6), C-reactive protein (p = 0.4), prednisone cumulative dose (p = 0.8), and methotrexate cumulative dose (p = 0.8) were comparable in both groups. Cyclophosphamide use was reported in only 1 patient with reduced ovarian reserve, whereas none of the remaining patients received gonadotoxic drugs. Conclusion. To the best of our knowledge, our present study was the first to suggest that patients with TA may have diminished ovarian reserve.
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - FM/MOG
Departamento de Obstetrícia e Ginecologia - FM/MOG

Artigos e Materiais de Revistas Científicas - FM/MPE
Departamento de Pediatria - FM/MPE

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/ICr
Instituto da Criança - HC/ICr

Artigos e Materiais de Revistas Científicas - LIM/17
LIM/17 - Laboratório de Investigação em Reumatologia

Artigos e Materiais de Revistas Científicas - LIM/36
LIM/36 - Laboratório de Pediatria Clínica

Artigos e Materiais de Revistas Científicas - LIM/58
LIM/58 - Laboratório de Ginecologia Estrutural e Molecular


Files in This Item:
File Description SizeFormat 
art_MONT'ALVERNE_Reduced_Ovarian_Reserve_in_Patients_with_Takayasu_Arteritis_2014.PDF
  Restricted Access
publishedVersion (English)145.95 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.